RxDoctor Payments Data

Rajeev Buddi, MD

Retina Specialist · Neenah, WINPI 1700819281

Payments from drug & device makers

What this record shows

This record is dominated by ownership interests: $7,802 of the $7,819 with a category attached, or 99.8%. US Retina LLC accounts for 99.8% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2022 at $3,495 and has fallen 99.5% since, to $17 in 2024. Among retina specialist clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,819in general payments, 2019–2025

Across 7 payments — averaging $1117.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • US Retina LLC$8K
  • Apellis Pharmaceuticals, Inc.$17

What the payments were for

  • Education$170%
  • Ownership interest$7,802100%

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
US Retina LLC6$7,802
Apellis Pharmaceuticals, Inc.1$17

How this compares

$7,819 in reported general payments places this provider in the 90th percentile of 24 retina specialist providers in Wisconsin.

See all retina specialist providers in Wisconsin

Medicare billing

Part B allowed, 2024
$1,758,583
Medicare patients
375
Services billed
13,585

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate108$5,065
Ketorolac Tromethamine80$4,075
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat30$421

Paid to pharmacies, not to this prescriber.

Other retina specialist in Neenah

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →